Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 5 November 2026.

Announcements

6,266

Total raised

£165B

disclosed amounts

This month

£202M

raised so far

Seed
£5.0M

The financing was co-led by Amadeus Capital Partners and Manta Ray Ventures to support international expansion and product development.

"This investment allows us to expand our global reach, with sales and support engineering staff in Brazil, the US, India, and grow our Yorkshire headquarters. We will be adding engineers and production workers and moving into a new Sheffield location. The investment will also enable Sitehop to pursue its technology roadmap – fleshing out the range of SAFE products securing all types of data-in-motion, and developing parallel products using our world-class skillsets in cryptography and programmable hardware design. We aim to get Sitehop’s products into the backbone of most of the world’s networks in the next few years."
— Melissa Chambers, CEO
Seed
£140K

The funding comes from the Development Bank of Wales and Wesley Clover to support product development and sales expansion.

"As a legal technology business, we offer compliance management software that allows regulated businesses to save time and reduce costs with end-to-end compliance requirements."
— Ieuan Leigh, Chief Executive
Pre-Seed
£3.6M

The pre-series A round was backed by investors including AlbionVC and Ponderosa Ventures to support UK rollout and international expansion.

"We believe that Mondra’s footprinting solution can not only assist companies in meeting their scope 3 emissions reductions targets but can also support product development teams in improving products to meet the demands of end-consumers. In this way, we expect Mondra to help customers drive both impact and commercial outcomes."
— Chloë Payne, Investor
Series A
£40.5M

Pfizer Ventures led the financing round alongside Columbus Venture Partners and British Patient Capital.

"This financing will enable us to expand our team, progress our lead assets into the clinic and expand our drug discovery platform. We welcome our new investors alongside our existing strong syndicate and look forward to working together to take Curve to its next stage of growth."
— Simon Kerry, Chief Executive Officer